CLEC9A，也稱為DNGR1，被定義為具有單個細胞外C型凝集素結構域的II型膜蛋白。CLEC9A參與感染過程中的適應性免疫反應。此外，CLEC9A正在研究增強疫苗產生的免疫應答的潛力。 抗小鼠CD 370（1F 6）體內抗體-超低內毒素該產品同種型對照：Rat IgG1 Isotype Control for In Vivo - Low Endotoxin [GL113] (ICH2246) 緩沖液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 濃度：>2.0 mg/ml 純度：>98% by SDS-PAGE and HPLC 內毒素：≤ 0.5 EU/mg as determined by the LAL method 制劑：This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 – 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added. BSA and azide free
應用類型
Flow Cytometry, Immunofluorescence, Western Blot
免疫原
RBL-2H3 cells expressing mouse DNGR-1 fused to an HA epitope.
